Clinical trial Recruiting at 1 site Interventional Women only

Calcitonin added to bupivacaine for transversalis fascia plane block during cesarean delivery

Official title: Analgesic Effect of Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section, A Prospective Randomized Study

Run by Tanta University · NCT07033104 · Data updated 2026-11-12

This will see if adding calcitonin to bupivacaine in an ultrasound-guided transversalis fascia plane block gives better pain relief for women having cesarean delivery under spinal anesthesia.

More Transversalis Fascia Plane Block trials

Quick facts

Study typeInterventional
SexWomen only
Enrollment70 (estimated)
SponsorTanta University
Academic / other
Locations1 site (Tanta, Gharbia Governorate)
StatusRecruiting
StartedApril 1, 2025
Main results expectedAugust 1, 2025
Study endsSeptember 1, 2025
Registry record updatedJune 24, 2025
Trial IDNCT07033104 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women classified as ASA II who are scheduled for cesarean section under spinal anesthesia at the study site and who consent to participate.

Probably not a fit

Patients undergoing emergency cesarean, those with significant pregnancy-related medical conditions, ASA >3, coagulopathy, or those who refuse participation are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants at Tanta University Hospital will receive an ultrasound-guided transversalis fascia plane block with bupivacaine, with some patients also receiving calcitonin as an added adjuvant. The trial compares postoperative analgesia measures such as pain scores, duration of analgesia, and opioid consumption between groups. Eligible patients are women classified as ASA II scheduled for cesarean section under spinal anesthesia; exclusions include patient refusal, ASA >3, emergency cesarean section, pregnancy-related medical complications, or coagulopathy. The study is a single-center intervention using standard ultrasound-guided injection techniques performed by anesthesiology staff.

Why it matters

Potential benefit: If successful, adding calcitonin could prolong the block and reduce postoperative opioid needs after cesarean delivery.

How similar studies have gone: Using calcitonin as an adjuvant for peripheral nerve or fascial plane blocks is relatively novel with limited prior published evidence compared with more commonly used adjuvants.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* female pt ASA2 scheduled for cs under spinal anesthesia

Exclusion Criteria:

* patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy

Where it's running

  • tanta University hospital
    Tanta, Gharbia Governorate, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.